MSC-Derived Exosomes with NAD⁺

This innovative presentation explores the powerful synergy between Mesenchymal Stem Cell (MSC)-Derived Exosomes and Nicotinamide Adenine Dinucleotide (NAD⁺)—two cutting-edge agents in regenerative and cellular therapy. It begins with an introduction to exosomes, emphasizing their role as nanovesicles that facilitate intercellular communication and molecular transport. The presentation then delves into MSC-Derived Exosomes, highlighting their characteristics, immunomodulatory properties, and regenerative functions. Their potential in clinical settings is reinforced through a review of recent clinical trials and applications, ranging from anti-inflammatory treatments to tissue repair and neurodegenerative conditions.

In parallel, the presentation covers NAD⁺, a vital coenzyme central to energy metabolism, DNA repair, and cellular health. Topics include the NAD⁺ biosynthesis pathway, its systemic roles in the human body, and data from clinical trials that support its use in aging, cognitive decline, and metabolic disorders.

The core focus—MSC-Derived Exosomes with NAD⁺—examines the combined therapeutic value of these two agents. This fusion enhances delivery, bioavailability, and cellular uptake, offering a novel strategy for systemic rejuvenation and chronic disease intervention. Authored by Prof. Dato’ Sri Dr. Mike Chan, this presentation is ideal for healthcare professionals, researchers, and wellness practitioners seeking advanced, science-backed interventions.